| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MED.21432 |
| P698 | PubMed publication ID | 28128443 |
| P2093 | author name string | Erik F J de Vries | |
| Xiaoyun Zhou | |||
| Kiichi Ishiwata | |||
| Rudi A J O Dierckx | |||
| Hideo Tsukada | |||
| Aren van Waarde | |||
| Philip H Elsinga | |||
| Gert Luurtsema | |||
| Shivashankar Khanapur | |||
| P2860 | cites work | Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues | Q36778743 |
| A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier | Q36867354 | ||
| High homocysteine levels prevent via H2 S the CoCl2 -induced alteration of lymphocyte viability | Q37117183 | ||
| Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. | Q37150330 | ||
| Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | Q37157425 | ||
| Adenosine receptor agonists for promotion of dermal wound healing | Q37165218 | ||
| Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake | Q37172329 | ||
| Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction | Q37298281 | ||
| Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes | Q37325379 | ||
| The role of adenosine in Alzheimer's disease | Q37402673 | ||
| Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth | Q37540216 | ||
| Adenosine receptors in wound healing, fibrosis and angiogenesis. | Q37565195 | ||
| Adenosine receptors and cancer. | Q37565200 | ||
| Adenosine receptor ligands and PET imaging of the CNS. | Q37565222 | ||
| High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors | Q37636282 | ||
| Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline | Q37698085 | ||
| Adenosine, energy metabolism and sleep homeostasis | Q37802539 | ||
| Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging | Q37932582 | ||
| CD73: a potent suppressor of antitumor immune responses | Q38001161 | ||
| Adenosine: setting the stage for plasticity | Q38075271 | ||
| Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. | Q38098796 | ||
| Cardiovascular adenosine receptors: expression, actions and interactions | Q38114251 | ||
| Adenosine A(2A) receptor antagonists as Positron Emission Tomography (PET) tracers | Q38140938 | ||
| Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued | Q38200930 | ||
| Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer | Q38209586 | ||
| Efficacy of adenosine A2A receptor antagonist istradefylline as augmentation for Parkinson's disease: a meta-analysis of randomized controlled trials | Q38237288 | ||
| Adenosine receptor PET imaging in human brain | Q38245133 | ||
| An overview of adenosine A2A receptor antagonists in Parkinson's disease | Q38245134 | ||
| Adenosine receptor control of cognition in normal and disease | Q38245141 | ||
| Involvement of adenosine A2A receptors in depression and anxiety | Q38245143 | ||
| The effect of unpredictable chronic mild stress on depressive-like behavior and on hippocampal A1 and striatal A2A adenosine receptors. | Q38319918 | ||
| History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents | Q38395423 | ||
| Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned | Q38400990 | ||
| Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy | Q38406861 | ||
| Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers | Q24304896 | ||
| Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor | Q24323906 | ||
| Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions | Q24644038 | ||
| A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment | Q26749571 | ||
| Adenosine receptor signaling: a key to opening the blood-brain door | Q26795435 | ||
| Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress | Q27324798 | ||
| Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors | Q27343149 | ||
| Graft versus host disease: New insights into A2A receptor agonist therapy | Q28080809 | ||
| A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy | Q28087576 | ||
| Characterization and expression of the human A2a adenosine receptor gene | Q28117604 | ||
| Adenosine A2A receptors and depression | Q28190156 | ||
| Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats | Q28195202 | ||
| Medicinal chemistry of adenosine A2A receptor agonists | Q28207742 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Characterization of the Potent and Highly Selective A(2A) Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyraz olo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of | Q28239772 | ||
| Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment | Q28250207 | ||
| Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies | Q28256117 | ||
| Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function | Q28261240 | ||
| A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists | Q28283019 | ||
| Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice | Q28346715 | ||
| Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line | Q28363730 | ||
| Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients | Q28477288 | ||
| Functional cooperation of metabotropic adenosine and glutamate receptors regulates postsynaptic plasticity in the cerebellum | Q28507660 | ||
| Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder | Q28575557 | ||
| Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease | Q29346490 | ||
| Functional architecture of basal ganglia circuits: neural substrates of parallel processing | Q29618729 | ||
| Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death | Q30278868 | ||
| Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. | Q30304456 | ||
| Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment | Q30423298 | ||
| Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer | Q36620552 | ||
| CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis | Q36756800 | ||
| Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease | Q43901692 | ||
| Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. | Q43928004 | ||
| A biomathematical modeling approach to central nervous system radioligand discovery and development | Q44032522 | ||
| Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells | Q44094196 | ||
| Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis | Q44114291 | ||
| Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385. | Q44181417 | ||
| Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies | Q44234294 | ||
| The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. | Q44257111 | ||
| Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging | Q44267331 | ||
| Up-regulation of striatal adenosine A(2A) receptors in schizophrenia | Q44360359 | ||
| Istradefylline: first global approval | Q44360692 | ||
| High expression of CD73 as a poor prognostic biomarker in human colorectal cancer | Q44385757 | ||
| The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. | Q44404719 | ||
| Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives | Q44428843 | ||
| Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated | Q44477698 | ||
| Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys | Q44509618 | ||
| Overexpression of CD73 in prostate cancer is associated with lymph node metastasis | Q44531613 | ||
| Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study | Q44629601 | ||
| Comparative pharmacological studies on the A2 adenosine receptor agonist 5'-n-ethyl-carboxamidoadenosine and its F19 isotope labelled derivative | Q44674613 | ||
| Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder | Q44686783 | ||
| Age-related changes in cardiac adenosine receptor expression. | Q44795040 | ||
| Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA. | Q44830958 | ||
| Adenosine A2A receptor deficient mice are partially resistant to limbic seizures | Q44873083 | ||
| Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice | Q44927020 | ||
| Changes in purine levels and adenosine receptors in kindled seizures in the rat. | Q44962342 | ||
| Effect of free radicals on adenosine A(2A) and dopamine D2 receptors in the striatum of young adult and aged rats | Q44963688 | ||
| Potential of [11C]TMSX for the evaluation of adenosine A2A receptors in the skeletal muscle by positron emission tomography | Q45089529 | ||
| Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. | Q45271414 | ||
| Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease | Q45298554 | ||
| The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea. | Q45298788 | ||
| The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease | Q45300428 | ||
| Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease | Q45302947 | ||
| Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models | Q45305389 | ||
| Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. | Q45946925 | ||
| Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. | Q46054884 | ||
| Adenosine A(2A) receptor modulation of hippocampal CA3-CA1 synapse plasticity during associative learning in behaving mice | Q46124293 | ||
| Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A(2a) adenosine receptors | Q46153879 | ||
| Association study of A2a adenosine receptor genetic polymorphism in panic disorder | Q46386938 | ||
| Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men. | Q46388832 | ||
| Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats. | Q46427356 | ||
| Adenosine A2A receptor hyperexpression in patients with severe SIRS after cardiopulmonary bypass | Q46454472 | ||
| Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. | Q46460712 | ||
| Sympathetic activity relates to adenosine A(2A) receptor gene variation in blood-injury phobia | Q46482339 | ||
| Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain | Q46529369 | ||
| Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice | Q46534022 | ||
| Evaluation of brain and whole-body pharmacokinetics of 11C-labeled diphenylhydantoin in rats by means of planar positron imaging system | Q46554743 | ||
| Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex | Q46574495 | ||
| Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: Signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1/2). | Q46681846 | ||
| Greater adenosine A(2A) receptor densities in cardiac and skeletal muscle in endurance-trained men: a [11C]TMSX PET study | Q46777864 | ||
| Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats | Q46779705 | ||
| Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. | Q46810705 | ||
| Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. | Q30423837 | ||
| Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats | Q30427346 | ||
| Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice | Q30427422 | ||
| Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist | Q30433096 | ||
| A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence | Q30433250 | ||
| Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 | ||
| Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction | Q30437433 | ||
| The role of adenosine A2A receptor signaling in bronchiolitis obliterans | Q30437818 | ||
| Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition | Q30443210 | ||
| Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury | Q30444009 | ||
| Adenosine A2A activation attenuates nontransplantation lung reperfusion injury | Q30444747 | ||
| Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients | Q30445339 | ||
| Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis | Q30446178 | ||
| Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia | Q30447546 | ||
| Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection | Q30450509 | ||
| Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety | Q30587153 | ||
| Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography | Q31588589 | ||
| Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine | Q31853178 | ||
| [(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain | Q31869332 | ||
| Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope | Q33155294 | ||
| Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism | Q33591276 | ||
| Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation | Q33615249 | ||
| Extracellular adenosine-mediated modulation of regulatory T cells | Q33878542 | ||
| Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission | Q33912758 | ||
| Adenosine in the central nervous system: release mechanisms and extracellular concentrations | Q33955930 | ||
| The roles of CD73 in cancer | Q34003164 | ||
| Measuring receptor occupancy with PET. | Q34023747 | ||
| Roles of adenosine and its receptors in sleep-wake regulation | Q34041863 | ||
| Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography | Q34067336 | ||
| Adenosine receptor signaling modulates permeability of the blood-brain barrier. | Q34216355 | ||
| Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. | Q34462015 | ||
| The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. | Q34489136 | ||
| Adenosine and sleep-wake regulation | Q34550187 | ||
| Homeostatic control of brain function - new approaches to understand epileptogenesis. | Q43090447 | ||
| Test-retest variability of adenosine A2A binding in the human brain with (11)C-TMSX and PET. | Q43104979 | ||
| Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality | Q43119816 | ||
| Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices | Q43192912 | ||
| Lipopolysaccharide and TNF-alpha modify adenosine A(2A) receptor expression and function in equine monocytes. | Q43200122 | ||
| Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate | Q43269361 | ||
| Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors | Q43270185 | ||
| A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease | Q43272318 | ||
| Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease | Q43282432 | ||
| How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo | Q43557989 | ||
| Adenosine enhances glial glutamate efflux via A2a adenosine receptors | Q43627485 | ||
| Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder | Q43714688 | ||
| In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261. | Q43808697 | ||
| Evaluation of [4-O-methyl-(11)C]KW-6002 as a potential PET ligand for mapping central adenosine A(2A) receptors in rats | Q43825588 | ||
| Blockade of A(2A) adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia | Q43887494 | ||
| CD73-adenosine: a next-generation target in immuno-oncology | Q38711094 | ||
| Adenosine receptors in brain: neuromodulation and role in epilepsy | Q38747116 | ||
| CD73 is associated with poor prognosis in high-grade serous ovarian cancer | Q38835904 | ||
| Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor | Q38841915 | ||
| Effect of hyperoxic and hyperbaric conditions on the adenosinergic pathway and CD26 expression in rat. | Q38872376 | ||
| Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses | Q38910729 | ||
| Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor | Q38978881 | ||
| Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b. | Q38988738 | ||
| Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist | Q39011210 | ||
| CD73-deficient mice are resistant to carcinogenesis | Q39384112 | ||
| Fall in oxygen tension of culture medium stimulates the adenosinergic signalling of a human T cell line. | Q39396959 | ||
| Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists | Q39514425 | ||
| Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. | Q39531156 | ||
| Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells. | Q39664323 | ||
| DNA methylation regulates adenosine A(2A) receptor cell surface expression levels. | Q39764820 | ||
| A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments | Q39785317 | ||
| Modulation of adenosine A1 and A2A receptors in C6 glioma cells during hypoxia: involvement of endogenous adenosine. | Q40006549 | ||
| Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields | Q40183574 | ||
| Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. | Q40276687 | ||
| Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. | Q40314032 | ||
| Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells | Q40339055 | ||
| CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer | Q40646654 | ||
| Evidence for Coordinated Induction and Repression of Ecto-5'-Nucleotidase (CD73) and the A2a Adenosine Receptor in a Human B Cell Line | Q40652135 | ||
| From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy | Q40729839 | ||
| Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. | Q40779392 | ||
| Adenosine receptor subtypes | Q40808680 | ||
| Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain | Q41032052 | ||
| The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake | Q41075372 | ||
| A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system | Q41204066 | ||
| Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors | Q41385155 | ||
| The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma | Q41441746 | ||
| Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor | Q41545207 | ||
| Inhibition of small HA fragment activity and stimulation of A2A adenosine receptor pathway limit apoptosis and reduce cartilage damage in experimental arthritis. | Q41685843 | ||
| Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors | Q41700452 | ||
| A2A adenosine receptor deletion is protective in a mouse model of Tauopathy | Q41755392 | ||
| Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss | Q41776277 | ||
| Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils | Q42046896 | ||
| Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment | Q42094877 | ||
| [11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats | Q42354388 | ||
| Autoradiographic comparison of in vitro binding characteristics of various tritiated adenosine A2A receptor ligands in rat, mouse and pig brain and first ex vivo results. | Q42455807 | ||
| Distribution of adenosine A2 receptor mRNA in the human brain | Q42469615 | ||
| Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease | Q42494225 | ||
| Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors | Q42536513 | ||
| Treadmill running frequency on anxiety and hippocampal adenosine receptors density in adult and middle-aged rats | Q42624014 | ||
| Regulation of leukocyte migration across endothelial barriers by ECTO-5'-nucleotidase-generated adenosine | Q42634450 | ||
| Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation | Q42646895 | ||
| An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers | Q42655771 | ||
| Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory. | Q42701014 | ||
| Positive allosteric modulation of the adenosine A2a receptor attenuates inflammation | Q43052140 | ||
| The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices | Q43078271 | ||
| Adenosine A2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment | Q43088167 | ||
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
| Effect of Caffeine Chronically Consumed During Pregnancy on Adenosine A1 and A2A Receptors Signaling in Both Maternal and Fetal Heart from Wistar Rats | Q34709509 | ||
| Brain adenosine A2A receptor occupancy by a novel A1/A2A receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect | Q34786391 | ||
| Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet | Q34824112 | ||
| Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia | Q34842221 | ||
| Applications of adenosine receptor ligands in medical imaging by positron emission tomography | Q34947203 | ||
| Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses | Q34957647 | ||
| Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway | Q35014590 | ||
| A2A adenosine receptor protects tumors from antitumor T cells. | Q35016529 | ||
| Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice. | Q35046240 | ||
| Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists | Q35090797 | ||
| Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. | Q35098311 | ||
| Human brain endothelial cells are responsive to adenosine receptor activation | Q35136806 | ||
| Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. | Q35167540 | ||
| Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. | Q35410561 | ||
| Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts | Q35587846 | ||
| A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability | Q35630252 | ||
| Stimulation of Glia Reveals Modulation of Mammalian Spinal Motor Networks by Adenosine. | Q35739759 | ||
| Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population. | Q35759035 | ||
| Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease | Q35799088 | ||
| The discovery of a selective and potent A2a agonist with extended lung retention | Q35822325 | ||
| Tissue distribution of adenosine receptor mRNAs in the rat. | Q35873795 | ||
| A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release | Q35907768 | ||
| Adenosine dysfunction in epilepsy | Q36036212 | ||
| Adenosine A2A receptor activation prevents wear particle-induced osteolysis | Q36067491 | ||
| The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. | Q36075960 | ||
| Growth regulation of the vascular system: an emerging role for adenosine | Q36193019 | ||
| Pharmacological blockade of adenosine A2A receptors diminishes scarring | Q36252358 | ||
| Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors | Q36380776 | ||
| Adenosine A2A receptor plays an important role in radiation-induced dermal injury | Q36385392 | ||
| Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. | Q36466181 | ||
| Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells | Q36496998 | ||
| The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain | Q36522674 | ||
| Neurotransmitters and neuromodulators in the basal ganglia | Q36586002 | ||
| Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats | Q46842748 | ||
| Effect of adenosine A2A receptor activation in murine models of respiratory disorders | Q46844203 | ||
| N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors | Q46876692 | ||
| Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics | Q46907529 | ||
| The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study | Q46927153 | ||
| Improved spatial recognition memory in mice lacking adenosine A2A receptors | Q46977578 | ||
| Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation | Q47308949 | ||
| Activation of adenosine receptor potentiates the anticonvulsant effect of phenytoin against amygdala kindled seizures | Q48026821 | ||
| Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats | Q48103969 | ||
| Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration | Q48109713 | ||
| Changes in adenosine receptors in the neonatal rat brain following hypoxic ischemia | Q48110047 | ||
| Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat. | Q48116633 | ||
| The role of adenosine A1 and A2A receptors of entorhinal cortex on piriform cortex kindled seizures in rats | Q48147257 | ||
| Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors. | Q48209802 | ||
| Expression of adenosine A2a receptors gene in the olfactory bulb and spinal cord of rat and mouse | Q48260829 | ||
| Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia | Q48264449 | ||
| Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography | Q48336994 | ||
| Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex. | Q48369377 | ||
| Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents | Q48403772 | ||
| Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice | Q48410779 | ||
| Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain | Q48440230 | ||
| Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress | Q48488684 | ||
| Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis | Q48491942 | ||
| Differential effects of age on human striatal adenosine A₁ and A(2A) receptors. | Q48496249 | ||
| Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2 | Q48498628 | ||
| Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder | Q48530599 | ||
| Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain | Q48829546 | ||
| Maternal glutamate intake during gestation and lactation regulates adenosine A₁ and A(2A) receptors in rat brain from mothers and neonates | Q48854281 | ||
| The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain | Q48905814 | ||
| Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus. | Q48943968 | ||
| Detection of subclinical synovitis with macrophage targeting and positron emission tomography in patients with rheumatoid arthritis without clinical arthritis | Q49173312 | ||
| The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade | Q50262179 | ||
| Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia. | Q50480825 | ||
| Quantification of Dynamic 11C-Phenytoin PET Studies. | Q50889203 | ||
| A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients. | Q50989087 | ||
| Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats. | Q51028680 | ||
| A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats. | Q51329119 | ||
| Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels. | Q53093570 | ||
| A long-term study of istradefylline safety and efficacy in patients with Parkinson disease. | Q53579832 | ||
| Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. | Q54046112 | ||
| Brain regional pharmacokinetics of 11C-labeled diphenylhydantoin: positron emission tomography in humans. | Q54498084 | ||
| Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. | Q54532556 | ||
| Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression. | Q54569706 | ||
| Adenosine receptors and wound healing. | Q55008833 | ||
| Adenosine receptors and wound healing, revised. | Q55339762 | ||
| Synthesis of [3-N-(11) C-methyl]temozolomide via in situ activation of 3-N-hydroxymethyl temozolomide and alkylation with [(11) C]methyl iodide. | Q55460168 | ||
| Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease | Q57655621 | ||
| Extracellular Adenosine, Inosine, Hypoxanthine, and Xanthine in Relation to Tissue Nucleotides and Purines in Rat Striatum During Transient Ischemia | Q57982925 | ||
| P577 | publication date | 2017-01-27 | |
| P1433 | published in | Medicinal Research Reviews | Q2436033 |
| P1476 | title | Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging |
| Q90198060 | Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development |
| Q64106725 | Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development |
| Q61455308 | Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics |
| Q90413767 | Molecular docking and network connections of active compounds from the classical herbal formula Ding Chuan Tang |
| Q57896358 | The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease |
Search more.